Skip to main content
Clinical Trials/NCT03734666
NCT03734666
Completed
N/A

Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation

H. Lee Moffitt Cancer Center and Research Institute1 site in 1 country67 target enrollmentJanuary 14, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tobacco Use
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Enrollment
67
Locations
1
Primary Endpoint
Aim 2: Participant Retention
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.

Detailed Description

This study evaluates a mindfulness-based treatment to concurrently target cigarette smoking and alcohol use behaviors in adults. Aim 1: Modify an existing mindfulness-based treatment to include a focus on smoking cessation and reduced alcohol use. Aim 2: Evaluate benchmarks regarding the feasibility and acceptability of Mindfulness Based Relapse Prevention -Smoking and Alcohol Use. Aim 3: Collect and examine descriptive data on proximal and distal variables associated with increased smoking abstinence and reduced drinking.

Registry
clinicaltrials.gov
Start Date
January 14, 2019
End Date
November 4, 2021
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Currently smoking 3 or more cigarettes per day for the past year.
  • Carbon monoxide level \>/= 8 ppm(parts per million); should carbon monoxide level yield a result less than 8 ppm, participant will be asked to submit a urine sample to determine contine levels and the result must be \>/ level 3
  • Participant must be motivated to quit smoking and decrease alcohol use within the next 60 days
  • If male, consume \>/= 5 drinks and if female consume \>/= 4 drinks on at least 1 occasion in the past month
  • Willing and able to attend the 8 weekly group sessions
  • Valid home address in the Tampa Bay area
  • Functioning telephone number
  • Can speak, read and write in English
  • Inclusion Criteria Aim 2:

Exclusion Criteria

  • Unable to wear nicotine patch
  • Participants who have an active substance use disorder other than an alcohol use disorder
  • Participants who have an active psychotic disorder
  • Current use of tobacco cessation medications
  • Pregnant or nursing
  • Participants who have a household member already enrolled in the study.
  • In rare cases, study staff might exclude a participant for a reason not specified here

Outcomes

Primary Outcomes

Aim 2: Participant Retention

Time Frame: End of study at Week 16 Follow-up

Percentage of participants retained through follow-up

Aim 2: Rate of Recruitment of Eligible Participants

Time Frame: 20 weeks

Rate of recruitment was measured by calculating the average of eligible participants who were recruited per week

Aim 2: Number of Participants Scoring >3

Time Frame: End of Treatment at 8 Weeks

Number of participants scoring \>3. Patient satisfaction will be determined through a score on the Client Satisfaction Questionnaire Version 8 (Attkinson \& Greenfield), where participants respond to 8 items on a 4-point scale (1=very dissatisfied; 4=very satisfied). Results reported indicate clients with a patient satisfaction score over 80%.

Aim 2: Percentage of Participants That Completed Questionnaires

Time Frame: End of study at Week 16 Follow-up

Percentage of participants who completed questionnaires at week 16

Secondary Outcomes

  • Aim 3: Percentage of Heavy Alcohol Use at 16 Week Follow-up(At 16 week follow-up)
  • Aim 3: Percent of Heavy Alcohol Use at End of Treatment(End of Treatment at 8 Weeks)
  • Aim 3: Percent of Smoking Abstinence at 16 Week Follow-up(At 16 week follow-up)
  • Aim 3: Percent of Smoking Abstinence End of Treatment(End of Treatment at 8 Weeks)

Study Sites (1)

Loading locations...

Similar Trials